016790 — CanariaBio Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeSmall Cap

Annual cashflow statement for CanariaBio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	3,245	128	-725	-282,751	-208,328
Depreciation
Amortisation
Non-Cash Items	1,135	5,014	88.7	280,484	206,012
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	-10,661	7,218	5,010	-1,173	-6,536
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-5,478	13,209	5,275	-2,541	-7,910
Capital Expenditures	-601	-897	-7,773	-20,380	-28,481
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	4,003	-8,295	4,279	-22,772	17,207
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	3,402	-9,192	-3,494	-43,153	-11,274
Financing Cash Flow Items	—	—	—	-141	4,602
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	962	221	-2,461	47,047	24,521
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-1,114	4,238	-680	1,353	5,337